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Background: Patients with chronic liver disease frequently suffer from malnutrition, together with a decline in their
health-related quality of life.
This study was carried out with the aim of evaluating the nutritional status, complications of medical and surgical
care, anxiety, health-related quality of life and dependence level on basic and instrumental activities of daily living
in pre- and post-liver transplant patients.
Methods/Design: A prospective observational study with follow-up of patients on the waiting list for liver transplants
who subsequently received a transplant at the University Hospital Complex in A Coruña during the period 2012–2014
(n = 110).
All the patients will be followed-up for a maximum of 6 months. For survivors, assessments will be re-evaluated at one,
three and six months post- transplant.
Informed consent of the patient and ethical review board approval was obtained (Code: 2010/081 and 2010/082).
The following variables will be studied: socio-demographic data, reason for the transplant, comorbidity (Charlson Score),
analytical parameters, time on transplant waiting list and post-transplant complications. A trained nurse will
evaluate the following for each patient: nutritional indices, anthropometric variables and handgrip strength.
Validated questionnaires will be used to determine the patients’ nutritional status (Subjective Global Assessment),
anxiety (STAI questionnaire), Health-Related Quality of Life (LDQoL 1.0 questionnaire), dependence (Barthel Index and
Lawton-Brody Scale), nursing diagnoses (NANDA) and post-transplant quality indicators.
Multiple linear/logistic regression models will be used to identify variables associated with the events of interest.
Changes in nutritional status, quality of life and dependence over time will be analysed with linear mixed-effects
regression models.
Actuarial survival analysis using Kaplan-Meier curves, Cox regression and competitive risk will be performed
Concordance between the different scores that assess nutritional status and interobserver agreement regarding
nursing diagnoses will be studied using the statistical Kappa index and Bland Altman method.
Discussion: The risk of malnutrition can be considered as a possible prognostic factor in transplant outcomes,
associated with anxiety, health-related quality of life and dependence.
For this reason we consider interesting to perform a prospective follow-up study of patients who require a
transplant to survive, studying their nutritional status and health-related quality of life.
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The liver has a metabolic function, and when affected by
disease may lead to nutritional deficiency status, with liver
disease patients usually suffering from Protein-Energy
Malnutrition (PEM). Its appearance is caused by different
factors, which include inadequate food intake, abnormal
nutrient metabolism and altered digestion and absorption,
together with an increased catabolism and an increase in
protein-energy requirements [1-3].
The prevalence of malnutrition ranges from 25% to 80%
depending on the severity of the illness and the method
used to evaluate it [4,5]. In patients with decompensated
cirrhosis, malnutrition varies between 60% to 100% and
20% in patients with compensated cirrhosis [6].
Malnutrition is associated with progressive liver fail-
ure, as a result of which the most malnourished patients
have a worse prognosis for the illness, as morbidity and
mortality increases both before and after the transplant
[4,7]. It is associated with increased hospital admissions
and longer stays, raising costs both before and after the
transplant [5,8].
There is no consensus among authors as to which are
the most effective methods for assessing the nutritional
status of these patients, as the disease itself affects the
values obtained [4,6]. The most frequently used methods
include anthropometric parameters such as weight and
height in order to calculate the patient’s Body Mass
Index (BMI), Mid-Arm Circumference (MAC) and Tri-
ceps Skinfold Thickness (TSF) to calculate the Arm
Muscle Circumference (AMC), the Arm Muscle Area
(AMA) and Arm Fat Area (AFA) [1,2,5]. Analytical parame-
ters such as albumin, prealbumin, transferrin, total lympho-
cyte, total cholesterol, creatinine and proteins [2] help to
identify malnutrition and liver dysfunction [1,6].
Other methods used to assess the nutritional status in
cirrhotic patients are the Subjective Global Assessment
(SGA) [1,9] as well as handgrip strength, assessed with a
handgrip dynamometer [6,10,11]. Bioelectrical imped-
ance analysis [12,13] is also used, despite the fact that
some authors do not consider it very useful in patients
with oedema and ascites [4,6], or carrying out dietary
assessments using tools such as the Malnutrition Universal
Screening Tool (MUST) or Nutritional Risk Screening 2002
(NRS-2002) [4].
According to a number of studies, patients who are
candidates for liver transplants have a lower perception
of their Health-Related Quality of Life (HRQoL) than
the general population, which varies depending on the
underlying aetiology of the disease, being poorer in pa-
tients affected by hepatocellular carcinomas with alco-
holic and viral liver diseases [14-17].
The facets associated with HRQoL perceived as causing
the greatest concern are social isolation, depression and anx-
iety, sexual activity, tiredness and fatigue, gastrointestinalsymptoms and pain. Fatigue is a symptom presented
by 65% - 85% of the patients, the vast majority of whom
perceive it as one of the symptoms that is tolerated the
worst, causing incapacity to 25%. Generally these are symp-
toms that are minimised or not considered relevant in the
progress of the illness, although they do cause anxiety to
patients and can worsen their functional status [18-20].
The HRQoL is studied in relation to the progress of
the patient prior and subsequent to the liver transplant.
Various instruments exist that can be used to evaluate
the health-related quality of life. Amongst the generic in-
struments, the one considered to be the most relevant
and most widely used by different authors is the Medical
Outcomes Study Short Form-36 (SF-36) questionnaire,
which consists of 36 items split into 8 sections, covering
both physical and mental aspects [21-24].
Depending on the pathology being studied, specific
questionnaires are used to evaluate its different symp-
toms and signs. In the case of liver disease and subse-
quent liver transplantation, the most usual validated
questionnaire is the National Institute of Diabetes and
Digestive and Kidney Disease Liver Transplant Database
Quality of Life (NIDDK QOL) [23], which consists of 63
items split into 6 domains, covering aspects of social life
and physical capacity. The Chronic Liver Disease ques-
tionnaire (CLDQ) [22,23] is more specific and consists of
29 items split into 6 domains, which has been validated
for the Spanish population by Ferrer et al. The specific
questionnaire for liver disease and subsequent liver trans-
plantation, the Liver Disease Quality Of Life (LDQOL)
[18-20] questionnaire consists of 112 items divided into
20 domains and has been validated for the Spanish
population by Casanovas et al. This questionnaire has
two different parts: a generic part which is equivalent
to the SF-36 questionnaire [21] and a specific part on
the characteristics of the disease. The LDQOL is fre-
quently used as it contains a summarised version to
evaluate the specific problems of the study population.
Also, in order to provide more data on the health-
related quality of life of these patients, scales and indices
will be used that measure the effect on their dependence
in basic and instrumental activities of daily living (the
Barthel Index and Lawton-Brody Scale) [25-28].
During the process of the disease and subsequent
post-transplant recovery period, the patient may suffer
from alterations to their mood and anxiety that may in
turn affect the outcome of the disease [29].
Survival rates vary after liver transplants based on the
level of liver dysfunction, which is measured using the
Child-Pugh scales and MELD validated for this purpose.
Both scales are used to evaluate liver damage, and the
scores obtained are correlated with post-transplant
survival [30]. Not only the degree of liver dysfunction
should be considered as a prognostic factor, but factors
Table 1 Data collection during the follow-up
Variables Base line After Transplant






Anxiety assessment X X
Screening tool for
Nutritional assessment
X X X X
Analytical parametres X X X X
Health-related Quality
Of Life (HRQoL)
X X X X
Dependence X X X X









• Perioperatory mortality X
• Rate of liver
retransplantation
X X
• Rate of early
reintervention
X X
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trition, quality of life, dependence and anxiety can also
modify the outcome of the disease.
Evaluating the patient’s nutritional status could reduce
the appearance of complications before and after liver
transplants, improving their health-related quality of life
and reducing their dependence in basic and instrumental
activities of daily living [7,12].
We consider it to be of interest to carry out a pro-
spective follow-up study of patients affected by chronic
liver disease requiring a liver transplant to survive, study
their nutritional status and health-related quality of life
in a reference hospital for liver transplants at national
level.
Objectives:
1. To evaluate the nutritional status of patients before
and after liver transplantation at one, three and six
months post-surgery, and its connection with
complications of surgical and medical care.
2. To determine the health-related quality of life and
level of dependence in basic and instrumental activities
of daily living in patients with advanced chronic liver
disease on the pre-transplant list and subsequently
post-transplant at one, three and six months.
Secondary objectives:
1. To evaluate their state-trait anxiety before receiving
a liver transplant and six months after receiving the
transplant.
2. To determine the complications and quality
indicators of post-liver transplant as described by
the Spanish Liver Transplant Society (SETH)
3. To determine the concordance of the nursing
diagnoses (NANDA) made by two independent
observers
Methods/Design
This is a prospective observational study with follow-up,
including patients on the waiting list for a liver trans-
plant at the University Hospital Complex in A Coruña
(a tertiary level 1,400-bed hospital serving a population
of 516,000 in A Coruña, northwest Spain), between
January 2012 and December 2014, with a minimum
follow-up period of 6 months.
The study will include patients over the age of 18 who
join the waiting list for a liver transplant during the
study period, and who give their informed consent to
take part.
The study will exclude patients whose general condi-
tion means it is impossible to make a correct evaluation,
as well as those who decide not to take part on their
own initiative.Data collection
All of the variables that will be recorded for each of the
patients included in the study are summarized in Table 1
and Additional file 1: Table S2.
After accepting and signing the informed consent
form, the patient will be identified with a code that
makes it possible to keep their personal data confiden-
tial. In order to obtain the necessary information for the
study, their clinical records will be studied and the patient
will be interviewed, including self-administered question-
naires and a physical examination.
The patients’ clinical records will be used to com-
pile demographic data and how long they have been
on the transplant waiting list (interval in days from
when they joined the list until they received the trans-
plant). The following data will also be collected: types
of pathologies leading to transplantation (alcoholic
cirrhosis, autoimmune hepatitis, polycystic disease,
liver cancer, primary biliary cirrhosis and viral cirrhosis),
the presence of hepatic imbalances (ascites, hepatic en-
cephalopathy, digestive bleeding, bacterial peritonitis and/
or hepatorenal syndrome) and repeat transplantation.
Comorbidity will be determined using the age-adjusted
Charlson Score [31-34].
On joining the liver transplant waiting list and during
the subsequent follow-up, the physical examination will
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questionnaires in order to evaluate the following:
The degree of liver dysfunction will be evaluated as
a baseline measurement using the Child- Pugh Scale and
the Model for End Stage Liver Disease (MELD), indicating
that the higher the score, the greater the liver dysfunction.
The Child-Pugh Scale determines the prognosis and need
for transplantation, estimating the degree of liver dysfunc-
tion in these patients. The patients’ clinical records will be
used to obtain the analytical parameters (serum albumin,
bilirubin and prothrombin) and to identify the presence of
liver imbalances (ascites and encephalopathy), obtaining a
score ranging from 5 – 15 points [35,36]. MELD indicates
the severity of hepatic cirrhosis and is used to prioritise
patients on the waiting list for liver transplants. Based on
the laboratory parameters for total bilirubin, the Inter-
national Normalized Ratio (INR) and plasma creatinine, a
score interval of 6–40 points is obtained [37].
The patients’ anxiety level will be measured at the
baseline moment and then 6 months post-transplant using
the State Trait Anxiety Inventory questionnaire (STAI),
which will be self-administered without any time limit to
complete it [38]. This questionnaire consists of two scales
that measure the State Anxiety (S/A), which reflects what
the patient feels at the moment of completing the ques-
tionnaire, and the Trait Anxiety (T/A), which reflects how
the patient generally feels. Each scale consists of 20 items,
providing a score of between 0 and 60 points (where 0
represents the minimum level of anxiety and 60 the max-
imum level), making it possible to obtain the percentiles
according to sex and age, by comparing them with the
scale chart for the questionnaire.
Nutritional status, analytical parameters, Health-
Related Quality of Life (HRQoL), dependence in
basic and instrumental activities of daily living and
nursing diagnoses (NANDA) will be determined at the
baseline moment and during follow up at one, three
and six months post-transplant.
Nutritional status will be evaluated based on the
analytical parameters for albumin, cholesterol and total
lymphocytes, using the criteria of the Spanish Society
of Parenteral and Enteral Nutrition (SENPE), Controlling
Nutritional Status (CONUT) and the Nutritional Risk
Index (NRI) [10,39,40]. During the physical examin-
ation the patient’s weight, height and Body Mass Index
(BMI) will be obtained. Other anthropometric parame-
ters will be calculated, such as the Mid-Arm Circum-
ference (MAC) and Triceps Skinfold Thickness (TSF)
to obtain Arm Muscle Circumference (AMC), Arm
Muscle Area (AMA), Arm Fat Area (AFA) and the
muscle adipose index. Handgrip strength will also be
calculated, assessed with a handgrip dynamometer, as
this indicates the muscular fraction of the protein
compartment [10,11].The Subjective Global Assessment (SGA) [41] will be
applied, which consists of two parts: a clinical record
(change in weight and intake, gastro-intestinal symp-
toms, functional capacity and base disease) and a phys-
ical examination to evaluate the loss of fat/muscle mass,
the presence of ascites or oedemas, and the presence of
tongue or skin lesions.
The clinical record will also be used to obtain the
analytical parameters evaluated to be included on the
liver transplant list (haematocrit, haemoglobin, leukocytes,
albumin, total bilirubin, liver enzymes, alpha-fetoprotein,
urea, creatinine, sodium, potassium, glucose, prothrombin
time ratio, International Normalized Ratio (INR) and
Cytomegalovirus (CMV) infection. The study will also
take into account cholesterol, creatinine clearance and
total lymphocytes, in order to identify how the analytical
liver profile can be related to the nutritional status, health-
related quality of life and level of dependence [42,43].
Health-Related Quality of Life (HRQoL) will be
evaluated using the self-administered LDQOL 1.0 ques-
tionnaire, validated for the Spanish population and specif-
ically developed for patients with advanced liver cirrhosis,
especially for those on the liver transplant waiting list
[18-20], using its abbreviated version, which consists of
generic and specific dimensions. Eight generic dimensions
are obtained, summarised as a physical and mental compo-
nent, and eleven specific dimensions which are included
due to being identified as of concern for the patients,
which are Symptoms of liver disease (6 items), Effects of
liver disease (3 items), Concentration (2 items), Mem-
ory (2 items), Sexual functioning (3 items), Sexual
problem (2 items), Sleep (5 items), Loneliness (5 items),
Health distress (3 items), Hopelessness (2 items), and
Stigma of liver disease (4 items) [18-20,44].
Degree of dependence in basic and instrumental
activities of daily living
The Barthel Index will be used to evaluate basic activities,
which was developed to assess changes in functional inde-
pendence before and after surgery and/or treatments, and
to identify the amount of care required. It is based on 10
observed items which are scored in increments of 5 (0, 5,
10, 15), with a maximum score of 100 and a minimum
score of 0, considered as the maximum level of depend-
ence [27]. To evaluate instrumental activities of daily
living, the Lawton-Brody scale will be used [28] which
makes it possible to evaluate functional activities based
on eight items scored from eight to zero, considered as
the maximum level of dependence [25-28].
Nursing diagnoses, considered as the basis for the
nurse’s care plan, will be studied according to the use of
NANDA’s taxonomy II (North American Nursing Diagnosis
Association) which consists of 13 domains and 46 classes
[45]. This evaluation will be carried out independently
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concordance.
Post-liver transplant complications and quality indicators
will be studied in the follow-up
The complications post - transplant which will be
evaluated are viral, bacterial and fungal infections and
surgical wound infections; acute or chronic graft rejec-
tion; bleeding; anastomotic stenosis of the bile duct;
thrombosis of the hepatic arteries and/or veins; repeat
transplantation; repeat surgery and death.
Post-liver transplant quality indicators, described in
the Consensus document of the Spanish Liver Trans-
plantation Society [46] : Perioperative mortality (at one
month), Post-liver transplant in-hospital mortality (at 3
and 6 months), Rate of early re-intervention (at 3 and
6 months) and Rate of liver re-transplantation (at
6 months).
Sample size
Sample size is limited by both the duration of the study
and the number of liver transplants per year. During the
period 2012–2014, approximately n = 120 patients will
receive a liver transplant. Assuming a loss to follow-up
rate of 10%, a sample size of n = 107 patients is expected.
In relation with different objectives (prevalence, longi-
tudinal data and prognosis) the sample is justified as de-
tailed below.
Prevalence
This sample size will allow us to estimate characteristics
about nutritional status, quality of life and dependence
with a precision of ±10% for a security: 95% (α = 0.05),
assuming a prevalence of 50% of the variable of interest,
assuming 10% losses during the follow-up.
Longitudinal data
As quality of life will be assessed using the LDQOL 1.0
questionnaire, based on its 0–100 scoring system, and
using range rule of thumb, a standard deviation of 25
points (one quarter of the range score) is assumed for
the final scores for the questionnaire. Therefore, a sam-
ple size of n = 107 patients will allow us to estimate
mean values with a precision of ±0.1 for a security: 95%
(α = 0.05). Working with a power of 80% and an alpha
value of 0.05, score differences of 4.5 points between
groups of patients will be detected as statistically signifi-
cant, assuming an exposure of 50% to the variable of
interest.
This sample size will also make it possible to detect as
statistically significant (p ≤0.05) correlation coefficients
≥0.15 among the studied variables and the questionnaire
scores.Prognosis
This sample size will also make it possible to detect as
significant, in a Cox regression model, a relative risk of
1.9 or more associated with risk of malnutrition, assum-
ing an exposure to this possibility of 63.4% and a cen-
sored data percentage of 10% obtained from previous
data; security: 95% (α = 0.05); statistical power: 80%, as-
suming an exposure prevalence of 63.4% malnutrition
risk according to CONUT at the time of being included
on the liver transplant list [47].
In terms of the censoring value, we have estimated it
at 20%, as according to published data [48] the estimated
post-liver transplant survival rate at six months is 80%.
In this situation, the sample size required to estimate a
relative risk of 1.85 or more (α = 0.05, β = 0.2) would be
n = 105 patients.
Statistical analysis
Descriptive analyses will be performed for all variables.
Continuous variables will be reported using means ±
standard deviations (SD) or median (interquartile range).
For dichotomous/categorical variables, absolute numbers
and percentages will be calculated, together with their
95% confidence intervals.
Nutritional status, quality of life related to health and
dependence scores will be compared according to the
patients’ characteristics and disease variables. The com-
parison of means will be carried out using Student’s T
test, the Mann–Whitney test, analysis of ANOVA test
and the Kruskall-Wallis test as appropriate. The associ-
ation of qualitative variables will be carried out using
Chi-square statistics. The correlation among quantitative
variables will be assessed using Pearson and Spearman’s
Rho correlation coefficient, due to the expected non-
normal distribution of the questionnaires scores and to
detect nonlinear relationships.
Evolution of nutritional status, health-related quality
of life (HQRoL) and dependence before transplantation
and at one, three and six months post-transplant from
diagnosis will be analysed based on the change from the
baseline scores for each time point. The significance of
the changes will be assessed using the Wilcoxon signed-
rank test. Clinical relevance will be analysed by effect
size and Standard Error of Measurement (SEM). Finally,
a value greater than 1 SEM will be considered as clinic-
ally significant.
As measurements of nutritional status, QOL and de-
pendence will be made repeatedly for the same patients,
we will be in a repeated measures context. Longitudinal
nutritional status, QOL and dependence will be analysed
with a linear mixed-effects regression model. More spe-
cifically, the relationship of these outcomes with time
will be determined using a random coefficients model,
which generalizes linear regression techniques to allow
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count the correlation within observations on the same
subject and allow for the inclusion of data on subjects
who have only partial follow-up without imputing miss-
ing data.
Therefore, a linear random coefficient regression model
will be performed, with nutritional status, QOL and de-
pendence scores over time as the dependent variable. The
connection with nutritional status, QOL, dependence and
time will be modelled by including a quantitative time ef-
fect (months since from the listing for liver transplant-
ation) as a covariate in the model, fitting patient effect and
patient*time interaction as random effects. In addition to
the effect of time on the nutritional status, QOL and de-
pendence outcome measures, we will incorporate other
factors into the regression models, in order to adjust for
the variables of interest and potential confounding factors
such as socio-demographic variables, hepatic dysfunction,
comorbidity, analytical parameters, anxiety and follow-up
complications.
In the multivariate analysis, multiple linear and logistic
regression models will be used to identify those variables
independently associated with patients’ nutritional sta-
tus, quality of life (QOL) and dependence before and
after transplantation. Separate regressions will be con-
ducted for each of the three outcomes (nutritional sta-
tus, quality of life, dependence). Box-Cox normalizing
transformations will be used when necessary to ensure
the normality assumption in the linear regression model.
Actuarial survival analysis with Kaplan-Meier curves,
log-rank test and Cox regression analysis will be per-
formed. The assumption of hazards proportionality will
be assessed using different procedures: a) a log-minus
log survival plot for each covariate, b) by analysis of scaled
Schöenfeld residuals and c) by tests of interaction between
categorized variables and time in the Cox model.
In case of violation of the hazard proportionality as-
sumption for any of the covariates, an interaction term
between the covariate and time will be included in the
Cox regression model. Additionally, survival regression
models using B-spline functions and U-shape graphs will
be explored in order to model non-proportional hazards.
These calculations will be performed by using the func-
tions available in the survival package in R (version
2.10.0). As the Kaplan-Meier method could overestimate
the incidence of the events in the follow-up, a competi-
tive mortality risk survival analysis will also be consid-
ered for analysing disease-specific survival [49,50].
The analysis of the perioperative survival rate, post-
transplant hospital survival rate, early intervention rate
and repeat liver transplant rate will be carried out in a
similar way to the analysis of the global survival rate.
Concordance between the different scores that assess
nutritional status and interobserver agreement regardingnursing diagnoses at baseline and at 6 months post-
transplant, will be studied with the statistical Kappa
index and Bland Altman method.
Two-sided tests will be used, and p-values < 0.05 will be
considered as statistically significant. Statistical analyses
will be performed using SPSS for Windows (version 19.0,
SPSS Inc., Chicago, Illinois), Stata (version 10) and R
(version 2.12.2).Legal and ethical aspects
The study will be carried out according to the Good
Clinical Practice guidelines of the Helsinki declaration,
and the confidentiality of the information collected is
guaranteed under current legislation. Informed consent
is obtained from each patient to take part in the study
and to review their clinical records. This project has
been approved by the corresponding ethics review board
(Clinical Research Ethical Committee of Galicia, decision
2010/081 and 2010/082).Discussion
The literature shows that the severity of liver dysfunc-
tion is associated with nutritional deficiencies and the
presence of anxiety or the level of stress of the patient
undergoing a liver transplant. Studies exist which show
that more severe liver dysfunction is associated with a
higher level of anxiety, which decreases post-surgery.
This change in the levels of anxiety would be associated
with an improvement in the patient’s health-related
quality of life [51].
Because of these changes, it is important to know the
nutritional status of the patient, as this is a risk factor
for morbidity-mortality which is correlated with the se-
verity of the liver dysfunction [52], both before and after
the transplant [5,7]. It is not easy to know the incidence
of malnutrition, as the parameters can be altered by the
pathology itself [2,3], and so this is why it is necessary to
use different methods in order to determine it, as there
is no gold standard [2,40].
In order to evaluate the nutritional status, methods are
used which are easy to apply, more economic and non-
invasive, such as anthropometric and analytical parame-
ters, and questionnaires on the patient’s normal intake.
In this case it is advisable to use two or more, in order
to compare them and determine the nutritional status of
the patients or population groups being studied [40].
The most frequently used anthropometric parameters
are the BMI, although this is not considered to be a reli-
able tool [2] as there may be changes in terms of body
composition (such as the presence of oedemas or asci-
tes). Anthropometric measurements of the upper limbs
are more accepted, such as the Triceps Skinfold Thick-
ness, Mid-Arm Circumference, Arm Muscle Area and
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obtain the muscle adipose index.
As some authors consider anthropometrics to be a
method that underestimates the nutritional status of
patients with liver disease [55], validated scores will also
be obtained, such as the Controlling Nutritional Status
(CONUT) [39], SENPE criteria and Nutritional Risk Index
(NRI). These indices are calculated based on analytical pa-
rameters such as albumin (an indicator of the visceral pro-
tein levels), lymphocytes (an indicator of immunological
function) and cholesterol (an indicator of malnutrition, re-
lated to the mortality of the patient), which make it possible
to evaluate the patient’s nutritional status in combination
with their weight or BMI. There is moderate concordance
between them, according to the study of Gimeno et al. [40].
The SGA and handgrip with handgrip dynamometer
will be used, as these are considered as techniques for
determining nutritional status. The hand grip can also
be considered as a tool that predicts the likelihood of
malnourished patients from suffering complications [56].
The indicators of nutritional status may also be used
as prognostic factors.
The triceps skinfold thickness (TSF) and the Mid-Arm
Circumference (MAC) can be considered as independent
prognostic factors, as patients with muscular depletion and/
or severe or moderate fat have a lower survival rate [53].
The Controlling Nutritional Status (CONUT) is an-
other method used by various authors which has been
studied as an indicator of survival, which has proved to
be a useful tool with a predictive power for 4-year post-
liver transplant mortality in patients with advanced liver
disease [57].
The treatment of chronic liver disease has changed and
improved considerably in recent years, which means that
imbalances such as gastro-intestinal bleeding, hepatorenal
syndrome or bacterial peritonitis have a better prognosis,
significantly increasing the survival of patients and the
possibilities of undergoing the transplant in a better phys-
ical and mental status [15,44]. For this reason it is consid-
ered important to know the Health-Related Quality of Life
(HRQoL) before the transplant and its outcome.
A significant improvement of the HRQoL is seen in
the vast majority of patients, especially in terms of body
image, self-esteem, taking part in active life and the abil-
ity to make plans [58].
The HRQoL and dependence in basic and instru-
mental activities of daily living include physical, men-
tal and social aspects. These aspects have a significant
impact on the success of a medical intervention, not
only in terms of survival but also in terms of nursing
care, as this includes aspects of daily life and social
functioning [59].
Once the transplant has been carried out, the patient’s
progress will depend on their initial status, as the severityof the liver dysfunction and the presence of complications
are associated with a higher morbidity-mortality [4]. The
most usual complications include bacterial infections,
acute/chronic rejection or CMV infection [60]. There
are also complications that may depend more on the
aetiology of the transplant, with a higher incidence of
repeat transplantation in patients with HCV than those
with alcoholic hepatitis [61]. Other causes of repeat
transplantation are acute/chronic rejection, hepatic ar-
tery thrombosis or graft dysfunction.
The post- transplant survival rate is estimated to be
80% after one year and 73% after five years [60], and is
lower in patients who have undergone repeat transplant-
ation: 67% after 3 years and 50% after 5 years [62].
This study will allow us to understand the connection
between the nutritional status, the prognosis, quality of
life and functional status in patients who have received
liver transplants, as well as the evolution of their nutri-
tional status before and after surgery.
Limitations of the study
The selection bias determined by the inclusion/exclusion
factors are the first limitation to the study, as patients
will be included who meet the inclusion criteria regard-
less of the stage of their liver disease. A check will be
made to verify if the results obtained are consistent with
the literature.
The information bias is a result of the way in which the
data are obtained. In order to minimise this bias, validated
questionnaires will be used. To minimise the Observer or
“Hawthorne” effect, self-administered questionnaires will
be used, to prevent the interviewer from influencing the
patient’s replies in any way.
It will be assumed that there may be information loss
in relation to measuring the dynamometric variables if
any of the patients have any kind of pathology or injuries
to their upper limbs (such as arthritis, arthrosis or frac-
tures), which have been taken into account when calcu-
lating the sample size.
In order to avoid any possible bias in relation to the
measurements, these will be carried out by the same
trained personnel.
Survivor selection bias is always present in follow-up
studies with patients who live longer, unlike those that do
not. The consistency of the results with different studies
will provide us with information about the external valid-
ity of the results.
In order to control for confounding variables, a multi-
variate statistical analysis will be performed.
Additional file
Additional file 1: Table S2. Baseline and post-transplant study
measurements.
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